A First-in-Human, randomised, double blind, placebo-controlled, single ascending dose trial to evaluate safety, tolerability, and pharmacokinetics of APC148 in healthy adults.
APC148-001
Phase 1 other active
Quick answer
A First-in-Human, randomised, double blind, placebo-controlled, single ascending dose trial to evaluate safety, tolerability, and pharmacokinetics of APC148 in healthy adults. for Urinary tract infections (UTIs)/complicated UTI (cUTI) is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Urinary tract infections (UTIs)/complicated UTI (cUTI)
- Phase
- Phase 1
- Modality
- other
- Status
- active